Quarterly report pursuant to Section 13 or 15(d)

Stock Compensation (Tables)

v3.21.2
Stock Compensation (Tables)
 9 Months Ended
Sep. 30, 2021
Equity [Abstract]  
Summary of Stock-Based Instruments

The Company issued the following stock-based instruments:

 

 

Nine Months Ended September 30,

 

 

 

2021

 

 

2020

 

 

 

Granted

 

 

Weighted-Average Grant-Date Fair Value

 

 

Granted

 

 

Weighted-Average Grant-Date Fair Value

 

Restricted stock

 

 

699,300

 

 

$

43.40

 

 

 

1,069,300

 

 

$

36.52

 

Performance-based restricted stock

 

 

108,750

 

 

$

38.95

 

 

 

—

 

 

$

—

 

Market-based restricted stock

 

 

108,750

 

 

$

54.34

 

 

 

—

 

 

$

—

 
Summary of Unvested Shares

A summary of the status and changes of the Company’s unvested shares is presented below:

 

 

Shares

 

 

Weighted-Average Grant-Date Fair Value

 

Unvested at December 31, 2020

 

 

3,112,023

 

 

$

35.06

 

Granted

 

 

916,800

 

 

$

44.17

 

Vested

 

 

(1,072,858

)

 

$

34.34

 

Cancelled

 

 

(15,999

)

 

$

34.16

 

Unvested at September 30, 2021

 

 

2,939,966

 

 

$

38.17